David Wallon
Impact in
- Physiology top 0.1%
- Alzheimer's disease research and treatments
- Psychiatry and Mental health top 0.2%
- Dementia and Cognitive Impairment Research
Papers in
-
- Dementia and Cognitive Impairment Research 58
- Physiology 74
- Alzheimer's disease research and treatments 69
- Lysosomal Storage Disorders Research 3
- Co-authors
- Didier Hannequin (28 shared papers)Dominique Campion (17 shared papers)Thierry Frébourg (11 shared papers)David Maltête (24 shared papers)Anne Rovelet‐Lecrux (16 shared papers)Romain Lefaucheur (17 shared papers)Gaël Nicolas (16 shared papers)Stéphane Derrey (12 shared papers)
- Journals
- Journal of Alzheimer s Disease (20 papers)Alzheimer s & Dementia (19 papers)Neurology (9 papers)Molecular Psychiatry (7 papers)Nature Genetics (7 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
David Wallon
150 papers receiving 15.1k citations
David Wallon's Hit Papers
Peers
Comparison fields: 5 of 198
- Physiology 7.4k
- Psychiatry and Mental health 4.3k
- Neurology 1.9k
- Neurology 1.1k
- Genetics 1.7k
Countries citing papers authored by David Wallon
This map shows the geographic impact of David Wallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wallon more than expected).
Fields of papers citing papers by David Wallon
This network shows the impact of papers produced by David Wallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wallon. The network helps show where David Wallon may publish in the future.
Co-authors
The 25 scholars most cited alongside David Wallon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Hit paper breakdown → | 2013 | 3486 |
| 2 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Hit paper breakdown → | 2019 | 2140 |
| 3 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Hit paper breakdown → | 2022 | 1531 |
| 4 | Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease Hit paper breakdown → | 2014 | 1332 |
| 5 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease Hit paper breakdown → | 2017 | 764 |
| 6 | APOE and Alzheimer disease: a major gene with semi-dominant inheritance Hit paper breakdown → | 2011 | 553 |
| 7 | APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases Hit paper breakdown → | 2017 | 482 |
| 8 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease Hit paper breakdown → | 2021 | 309 |
| 9 | 2012 | 236 | |
| 10 | 2015 | 221 | |
| 11 | Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores Hit paper breakdown → | 2021 | 221 |
| 12 | 2013 | 185 | |
| 13 | 2014 | 169 | |
| 14 | Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease Hit paper breakdown → | 2022 | 157 |
| 15 | 2013 | 140 | |
| 16 | 2017 | 132 | |
| 17 | 2018 | 112 | |
| 18 | 2019 | 107 | |
| 19 | 2012 | 104 | |
| 20 | 2020 | 103 |
About David Wallon
David Wallon is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Neurology and Clinical Biochemistry, having authored 163 papers that have together received 15.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (69 papers), Dementia and Cognitive Impairment Research (58 papers), Amyotrophic Lateral Sclerosis Research (16 papers), Intracerebral and Subarachnoid Hemorrhage Research (9 papers), Neurological disorders and treatments (8 papers), Neurological diseases and metabolism (6 papers), Pluripotent Stem Cells Research (4 papers) and Lysosomal Storage Disorders Research (3 papers). The work is most often cited by research in Physiology (7.4k citations), Psychiatry and Mental health (4.3k citations), Neurology (1.9k citations), Neurology (1.1k citations) and Genetics (1.7k citations). David Wallon has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Didier Hannequin, Dominique Campion, Thierry Frébourg, David Maltête, Anne Rovelet‐Lecrux, Romain Lefaucheur, Gaël Nicolas, Stéphane Derrey, Olivier Martinaud and Cyril P. Pottier. Their work appears in journals such as Journal of Alzheimer s Disease, Alzheimer s & Dementia, Neurology, Molecular Psychiatry and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.